Factor XII Inhibitors Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Factor XII Inhibitors Market Report 2026

Name: Factor XII Inhibitors Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Type (Monoclonal Antibodies, Small Molecule Inhibitors, Other Drug Types), By Route Of Administration (Oral, Injectable, Other Routes Of Administration), By Application (Hereditary Angioedema, Thrombosis, Inflammatory Disorders, Other Applications), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Factor XII Inhibitors Market Overview

• Factor XII Inhibitors market size has reached to $1.4 billion in 2025

• Expected to grow to $2.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%

• Growth Driver: Rising Incidence Of Thrombotic Disorders Fueling The Growth Of The Market Due To Increasing Cases Of Blood Clots And Related Health Complications

• Market Trend: Novel Therapy Offers Effective Prevention Of Hereditary Angioedema Attacks

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Factor XII Inhibitors Market?

Factor XII inhibitors are therapeutic agents that block the activity of coagulation Factor XII, a protein that initiates the intrinsic pathway of blood clotting. They prevent the activation of downstream clotting processes without significantly affecting normal hemostasis. Their primary purpose is to reduce abnormal thrombosis and other clot-related disorders, offering a lower bleeding risk compared to traditional anticoagulants.

The main drug types of factor XII inhibitors are monoclonal antibodies, small molecule inhibitors, and others. Monoclonal antibodies are lab-made antibodies that specifically block Factor XII to prevent abnormal blood clotting with minimal bleeding risk. These are administered through oral, injectable, and other routes. These drugs are applied for hereditary angioedema, thrombosis, inflammatory disorders, and others, serving end-users such as hospitals, specialty clinics, research institutes, and others.

Factor XII Inhibitors Market Global Report 2026 Market Report bar graph

What Is The Factor XII Inhibitors Market Size and Share 2026?

The factor xii inhibitors market size has grown rapidly in recent years. It will grow from $1.4 billion in 2025 to $1.55 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to advancements in coagulation biology research, increasing incidence of thrombotic disorders, limitations of traditional anticoagulants, early-stage clinical success of fxii inhibition, growing investment in rare and specialty therapeutics.

What Is The Factor XII Inhibitors Market Growth Forecast?

The factor xii inhibitors market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to expansion of late-stage clinical trials, increasing demand for safer antithrombotic therapies, rising precision medicine adoption, growing regulatory support for novel anticoagulants, expansion of fxii inhibitors into inflammatory indications. Major trends in the forecast period include increasing development of non-bleeding anticoagulant therapies, rising focus on targeted coagulation pathway modulation, growing clinical evaluation of fxii selective inhibitors, expansion of rna-based and peptide therapeutics, enhanced use of precision drug design.

Book your 30 minutes free consultation with our research experts

Global Factor XII Inhibitors Market Segmentation

1) By Drug Type: Monoclonal Antibodies, Small Molecule Inhibitors, Other Drug Types

2) By Route Of Administration: Oral, Injectable, Other Routes Of Administration

3) By Application: Hereditary Angioedema, Thrombosis, Inflammatory Disorders, Other Applications

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Monoclonal Antibodies: Fully Human Monoclonal Antibodies, Humanized Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Bispecific Monoclonal Antibodies, Single-Chain Variable Fragment (scFv) Antibodies

2) By Small Molecule Inhibitors: Direct Factor XII Inhibitors, Allosteric Factor XII Inhibitors, Reversible Inhibitors, Irreversible Inhibitors, Peptidomimetic Inhibitors

3) By Other Drug Types: Peptide-Based Inhibitors, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotides, Combination Therapies

What Are The Drivers Of The Factor XII Inhibitors Market?

The rising incidence of thrombotic disorders is expected to propel the growth of the factor XII inhibitors market going forward. Thromboembolic disorders are conditions in which blood clots form in veins or arteries, potentially blocking blood flow and causing serious health complications. Thromboembolic disorders are increasing due to the rising prevalence of sedentary lifestyles, which contribute to poor blood circulation and a higher risk of clot formation. Factor XII inhibitors in thrombotic disorders help prevent abnormal clot formation by blocking the contact activation pathway without affecting normal hemostasis. This allows for effective thrombosis control with a lower risk of bleeding. For instance, in January 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, approximately 900,000 people in the United States are affected by venous thromboembolism, of which an estimated 60,000-100,000 Americans die annually, while many others experience long-term complications. Therefore, the rising incidence of thrombotic disorders is driving the growth of the Factor XII inhibitors industry.

The increasing focus on targeted therapies is expected to propel the growth of the factor XII inhibitors market going forward. Targeted therapies are treatments that specifically target and inhibit molecular abnormalities in cancer or other diseases to improve treatment precision and minimize harm to healthy cells. The rising focus on targeted therapies is primarily driven by the advancements in precision medicine, which enables personalized, more effective treatments based on individual genetic profiles. Factor XII inhibitors enhance targeted therapies by specifically modulating the intrinsic coagulation pathway, making them ideal for patients at risk of thrombotic disorders. They reduce the risk of bleeding compared with conventional anticoagulants by providing precise inhibition of Factor XII, improving treatment safety and efficacy. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from 5 approvals in 2022. Therefore, the increasing focus on targeted therapies is driving the growth of the factor XII inhibitors industry.

Key Players In The Global Factor XII Inhibitors Market

Major companies operating in the factor xii inhibitors market are Taylor & Francis Group, Santa Cruz Biotechnology Inc., CSL Limited, Bridge Medicines Inc., KalVista Pharmaceuticals Inc., Ovid Technologies Inc., Affinity Biologicals Inc., Lunac Therapeutics Ltd., Grantome LLC

Global Factor XII Inhibitors Market Trends and Insights

Major companies operating in the Factor XII Inhibitors market are focusing on developing innovative products, such as anti-FXIIa monoclonal antibodies, to enhance therapeutic precision and treatment effectiveness. Anti-FXIIa monoclonal antibodies are targeted biologics that inhibit activated factor XII to prevent abnormal clot formation while preserving normal hemostasis. For instance, in February 2025, CSL Behring GmbH, a Germany-based biopharmaceutical company, received manufacturing and marketing approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for ANDEMBRY (garadacimab) subcutaneous (S.C.) injection 200 mg pens. It is a novel, human anti-activated factor XII monoclonal antibody approved for the prevention of acute attacks of hereditary angioedema (HAE). It works by targeting activated factor XIIa, a key driver in the initiation of HAE attacks, and is administered via a convenient subcutaneous injection pen.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the factor XII inhibitors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Factor XII Inhibitors Market?

The factor XII inhibitors market consists of revenues earned by entities by providing services such as formulation development, drug delivery optimization, laboratory testing, diagnostic support, regulatory consulting, pharmacovigilance, and contract manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The factor XII inhibitors market also includes sales of anticoagulant formulations, combination therapies, diagnostic kits, research reagents, laboratory consumables, and supportive medical devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Factor XII Inhibitors Market Report 2026?

The factor xii inhibitors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the factor xii inhibitors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Factor XII Inhibitors Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.55 billion
Revenue Forecast In 2035	$2.34 billion
Growth Rate	CAGR of 11.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Type, Route Of Administration, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Taylor & Francis Group, Santa Cruz Biotechnology Inc., CSL Limited, Bridge Medicines Inc., KalVista Pharmaceuticals Inc., Ovid Technologies Inc., Affinity Biologicals Inc., Lunac Therapeutics Ltd., Grantome LLC
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Factor XII Inhibitors Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Factor XII Inhibitors Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Factor XII Inhibitors Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Factor XII Inhibitors Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Development Of Non-Bleeding Anticoagulant Therapies

4.2.2 Rising Focus On Targeted Coagulation Pathway Modulation

4.2.3 Growing Clinical Evaluation Of Fxii Selective Inhibitors

4.2.4 Expansion Of Rna-Based And Peptide Therapeutics

4.2.5 Enhanced Use Of Precision Drug Design

5. Factor XII Inhibitors Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Research Institutes

5.4 Pharmaceutical Companies

5.5 Contract Research Organizations

6. Factor XII Inhibitors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Factor XII Inhibitors Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Factor XII Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Factor XII Inhibitors Market Size, Comparisons And Growth Rate Analysis

7.3. Global Factor XII Inhibitors Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Factor XII Inhibitors Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Factor XII Inhibitors Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Factor XII Inhibitors Market Segmentation

9.1. Global Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Small Molecule Inhibitors, Other Drug Types

9.2. Global Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable, Other Routes Of Administration

9.3. Global Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hereditary Angioedema, Thrombosis, Inflammatory Disorders, Other Applications

9.4. Global Factor XII Inhibitors Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Research Institutes, Other End-Users

9.5. Global Factor XII Inhibitors Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fully Human Monoclonal Antibodies, Humanized Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Bispecific Monoclonal Antibodies, Single-Chain Variable Fragment (scFv) Antibodies

9.6. Global Factor XII Inhibitors Market, Sub-Segmentation Of Small Molecule Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Factor XII Inhibitors, Allosteric Factor XII Inhibitors, Reversible Inhibitors, Irreversible Inhibitors, Peptidomimetic Inhibitors

9.7. Global Factor XII Inhibitors Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Peptide-Based Inhibitors, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotides, Combination Therapies

10. Factor XII Inhibitors Market Regional And Country Analysis

10.1. Global Factor XII Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Factor XII Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Factor XII Inhibitors Market

11.1. Asia-Pacific Factor XII Inhibitors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Factor XII Inhibitors Market

12.1. China Factor XII Inhibitors Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Factor XII Inhibitors Market

13.1. India Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Factor XII Inhibitors Market

14.1. Japan Factor XII Inhibitors Market Overview

14.2. Japan Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Factor XII Inhibitors Market

15.1. Australia Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Factor XII Inhibitors Market

16.1. Indonesia Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Factor XII Inhibitors Market

17.1. South Korea Factor XII Inhibitors Market Overview

17.2. South Korea Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Factor XII Inhibitors Market

18.1. Taiwan Factor XII Inhibitors Market Overview

18.2. Taiwan Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Factor XII Inhibitors Market

19.1. South East Asia Factor XII Inhibitors Market Overview

19.2. South East Asia Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Factor XII Inhibitors Market

20.1. Western Europe Factor XII Inhibitors Market Overview

20.2. Western Europe Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Factor XII Inhibitors Market

21.1. UK Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Factor XII Inhibitors Market

22.1. Germany Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Factor XII Inhibitors Market

23.1. France Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Factor XII Inhibitors Market

24.1. Italy Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Factor XII Inhibitors Market

25.1. Spain Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Factor XII Inhibitors Market

26.1. Eastern Europe Factor XII Inhibitors Market Overview

26.2. Eastern Europe Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Factor XII Inhibitors Market

27.1. Russia Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Factor XII Inhibitors Market

28.1. North America Factor XII Inhibitors Market Overview

28.2. North America Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Factor XII Inhibitors Market

29.1. USA Factor XII Inhibitors Market Overview

29.2. USA Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Factor XII Inhibitors Market

30.1. Canada Factor XII Inhibitors Market Overview

30.2. Canada Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Factor XII Inhibitors Market

31.1. South America Factor XII Inhibitors Market Overview

31.2. South America Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Factor XII Inhibitors Market

32.1. Brazil Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Factor XII Inhibitors Market

33.1. Middle East Factor XII Inhibitors Market Overview

33.2. Middle East Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Factor XII Inhibitors Market

34.1. Africa Factor XII Inhibitors Market Overview

34.2. Africa Factor XII Inhibitors Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Factor XII Inhibitors Market Regulatory and Investment Landscape

36. Factor XII Inhibitors Market Competitive Landscape And Company Profiles

36.1. Factor XII Inhibitors Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Factor XII Inhibitors Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Factor XII Inhibitors Market Company Profiles

36.3.1. Taylor & Francis Group Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Santa Cruz Biotechnology Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bridge Medicines Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. KalVista Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Factor XII Inhibitors Market Other Major And Innovative Companies

Ovid Technologies Inc., Affinity Biologicals Inc., Lunac Therapeutics Ltd., Grantome LLC

38. Global Factor XII Inhibitors Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Factor XII Inhibitors Market

40. Factor XII Inhibitors Market High Potential Countries, Segments and Strategies

40.1 Factor XII Inhibitors Market In 2030 - Countries Offering Most New Opportunities

40.2 Factor XII Inhibitors Market In 2030 - Segments Offering Most New Opportunities

40.3 Factor XII Inhibitors Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Factor XII Inhibitors Market, Overview Of Key Products - Product Examples

Table 2: Global Factor XII Inhibitors Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Factor XII Inhibitors Market, Supply Chain Analysis

Table 4: Global Factor XII Inhibitors Market, Major Raw Material Providers

Table 5: Global Factor XII Inhibitors Market, Major Resource Providers

Table 6: Global Factor XII Inhibitors Market, Major Manufacturers (Suppliers)

Table 7: Global Factor XII Inhibitors Market, Major Distributors And Channel Partners

Table 8: Global Factor XII Inhibitors Market, Key Technologies & Future Trends

Table 9: Global Factor XII Inhibitors Market, Major Trends

Table 10: Global Factor XII Inhibitors Market, Major End Users

Table 11: Global Factor XII Inhibitors Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Factor XII Inhibitors Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Factor XII Inhibitors Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Factor XII Inhibitors Market - TAM, US$ Billion, 2025

Table 15: Global Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Factor XII Inhibitors Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Factor XII Inhibitors Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Factor XII Inhibitors Market, Sub-Segmentation Of Small Molecule Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Factor XII Inhibitors Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Factor XII Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Factor XII Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Factor XII Inhibitors Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Factor XII Inhibitors Market - Company Scoring Matrix

Table 98: Taylor & Francis Group Financial Performance

Table 99: Santa Cruz Biotechnology Inc. Financial Performance

Table 100: CSL Limited Financial Performance

Table 101: Bridge Medicines Inc. Financial Performance

Table 102: KalVista Pharmaceuticals Inc. Financial Performance

Table 103: Global Factor XII Inhibitors Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Factor XII Inhibitors Market, Competitive Dashboard

Table 105: Global Factor XII Inhibitors Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Factor XII Inhibitors Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 107: Global, Factor XII Inhibitors Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 108: Global, Factor XII Inhibitors Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Factor XII Inhibitors Market, Overview Of Key Products - Product Examples

Figure 2: Global Factor XII Inhibitors Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Factor XII Inhibitors Market, Supply Chain Analysis

Figure 4: Global Factor XII Inhibitors Market, Major Raw Material Providers

Figure 5: Global Factor XII Inhibitors Market, Major Resource Providers

Figure 6: Global Factor XII Inhibitors Market, Major Manufacturers (Suppliers)

Figure 7: Global Factor XII Inhibitors Market, Major Distributors And Channel Partners

Figure 8: Global Factor XII Inhibitors Market, Key Technologies & Future Trends

Figure 9: Global Factor XII Inhibitors Market, Major Trends

Figure 10: Global Factor XII Inhibitors Market, Major End Users

Figure 11: Global Factor XII Inhibitors Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Factor XII Inhibitors Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Factor XII Inhibitors Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Factor XII Inhibitors Market - TAM, US$ Billion, 2025

Figure 15: Global Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Factor XII Inhibitors Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Factor XII Inhibitors Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Factor XII Inhibitors Market, Sub-Segmentation Of Small Molecule Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Factor XII Inhibitors Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Factor XII Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Factor XII Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Factor XII Inhibitors Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Factor XII Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Factor XII Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Factor XII Inhibitors Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Factor XII Inhibitors Market - Company Scoring Matrix

Figure 98: Taylor & Francis Group Financial Performance

Figure 99: Santa Cruz Biotechnology Inc. Financial Performance

Figure 100: CSL Limited Financial Performance

Figure 101: Bridge Medicines Inc. Financial Performance

Figure 102: KalVista Pharmaceuticals Inc. Financial Performance

Figure 103: Global Factor XII Inhibitors Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Factor XII Inhibitors Market, Competitive Dashboard

Figure 105: Global Factor XII Inhibitors Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Factor XII Inhibitors Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 107: Global, Factor XII Inhibitors Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 108: Global, Factor XII Inhibitors Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Kinase Inhibitors Market Report 2026 - Global Outlook – By Type (Tyrosine Kinase Inhibitors, Multikinase Inhibitors, mTOR Kinase Inhibitors, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By A...

Antiglaucoma Drugs Market - By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Con...

Enzyme Inhibitor Market Report 2026 - Global Outlook – By Type (Proton Pump Inhibitors (PPIs), Protease Inhibitors, Reverse Transcriptase Inhibitors, Aromatase Inhibitors, Kinase Inhibitors, Neuraminidase Inhibitors, Sta...

Proteasome Inhibitors Market Report 2026 - Global Outlook – By Product (Velcade, Kyprolis, Ninlaro, Other Products), By Drugs (Bortezomib, Carfilzomib, Ixazomib), By Indication (Lymphoma, Mantle Cell Lymphoma, Multiple M...

Alpha Glucosidase Inhibitors Market Report 2026 - Global Outlook – By Type (Dumping Syndrome, Type 2 Diabetes), By Drug Class (Acarbose, Miglitol, Voglibose), By Constituent (Glucoamylase, Isomaltase, Maltase, Sucrase), ...

ACE Inhibitors Market Report 2026 - Global Outlook – By Type (Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents), By Drug (Ramipril, Enalapril, Benazepril, Fosinopril, Captopril...

Dipeptide Peptidase 4 Inhibitors Market Report 2026 - Global Outlook – By Type (Sitagliptin, Saxagliptin, Linagliptin, Alogliptin, Vildagliptin, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmaci...

Frequently Asked Questions

How big is the Factor XII Inhibitors Market?

The Factor XII Inhibitors market was valued at $1.4 billion in 2025, increased to $1.55 billion in 2026, and is projected to reach $2.34 billion by 2030.

What is the Factor XII Inhibitors market growth?

The global Factor XII Inhibitors market is expected to grow at a CAGR of 10.8% from 2026 to 2035 to reach $2.34 billion by 2035.

Who are the key players in Factor XII Inhibitors market?

Some Key Players in the Factor XII Inhibitors market Include, Taylor & Francis Group, Santa Cruz Biotechnology Inc., CSL Limited, Bridge Medicines Inc., KalVista Pharmaceuticals Inc., Ovid Technologies Inc., Affinity Biologicals Inc., Lunac Therapeutics Ltd., Grantome LLC .

What is the anticipated growth trend for the Factor XII Inhibitors market?

Major trend in this market includes: Novel Therapy Offers Effective Prevention Of Hereditary Angioedema Attacks. For further insights on this market. request a sample here

Which region has the most growth potential in the Factor XII Inhibitors market?

North America was the largest region in the factor XII inhibitors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the factor xii inhibitors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.